Regeneron Pharmaceuticals | REGN - Cash And Equivalent

Name: Regeneron Pharmaceuticals | REGN - Cash And Equivalent
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Regeneron,Pharmaceuticals,REGN,Cash,And,Equivalent,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals reported $3.92B in Cash and Equivalent for its fiscal quarter ending in March of 2023.

	Cash And Equivalent		Date
Agenus AGEN:US	USD 164.82M	13.85M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD 104.14M	35.12M	Mar/2023
Alimera Sciences ALIM:US	USD 13.09M	7.81M	Mar/2023
Alnylam Pharmaceuticals ALNY:US	USD 672.24M	194.15M	Mar/2023
Amgen AMGN:US	USD 31.56B	22.26B	Mar/2023
Astellas Pharma 4503:JP	JPY 376.84B	4.98B	Mar/2023
AstraZeneca AZN:LN	USD 6.23B	66M	Mar/2023
Biogen BIIB:US	USD 2.9B	521.1M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 580.07M	144.46M	Mar/2023
Bluebird Bio BLUE:US	USD 239.04M	126.04M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 9B	128M	Mar/2023
Eli Lilly LLY:US	USD 3.55B	1.48B	Mar/2023
Esperion Therapeutics ESPR:US	USD 144.91M	20.14M	Mar/2023
Gilead Sciences GILD:US	USD 7.2B	430M	Mar/2023
GlaxoSmithKline GSK:LN	GBP 2.89B	833M	Mar/2023
Incyte Corp INCY:US	USD 2.82B	130.37M	Mar/2023
Intercept Pharmaceuticals ICPT:US	USD 61.4M	10.89M	Mar/2023
Ionis Pharmaceuticals IONS:US	USD 309.03M	32.56M	Mar/2023
Iveric bio Inc. OPHT:US	USD 467.57M	8.73M	Mar/2023
J&J JNJ:US	USD 3.36B	2B	Mar/2023
Kyowa Hakko Kirin 4151:JP	JPY 344.85B	5.66B	Mar/2023
Moderna Inc MRNA:US	USD 3.44B	236M	Mar/2023
Neurocrine Biosciences NBIX:US	USD 103.8M	159.1M	Mar/2023
Novartis NOVN:VX	USD 12B	4.48B	Mar/2023
Novartis NVS:US	USD 12B	4.48B	Mar/2023
Opthea Ltd OPT:AU	USD 95.2M	62.42M	Dec/2022
Puma Biotechnology PBYI:US	USD 61.39M	14.81M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 3.92B	810.4M	Mar/2023
Roche Holding ROG:VX	CHF 4.99B	676M	Dec/2022
Sarepta Therapeutics SRPT:US	USD 871.67M	95.11M	Mar/2023
Seattle Genetics SGEN:US	USD 335.85M	15.91M	Mar/2023
Teva Pharmaceutical Industries Ltd TEVA:IT	USD 2.14B	658M	Mar/2023
Ultragenyx Pharmaceutical RARE:US	USD 85.77M	47.18M	Mar/2023
United Therapeutics UTHR:US	USD 1.16B	202.3M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 9.29B	1.21B	Mar/2023